ArticleMedComm2024

Tyrosine kinase inhibitors in HER2-positive metastatic breast cancer with trastuzumab emtansine resistance: insights from a multicenter retrospective real-world study.

Chunxiao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.